Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Low-Risk Polycythemia Vera

Conditions: Polycythemia Vera; Myeloproliferative Neoplasm Interventions: Drug: Ropeginterferon alfa-2b; Procedure: Phlebotomy Sponsors: PharmaEssentia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials